← Torna allo Screener

Dynavax Technologies

DVAX Small Cap

Healthcare · Drug Manufacturers - Specialty & Generic

Aggiornato: May 2, 2026, 22:05 UTC

13,22 €
+0% oggi

Metriche Chiave

P/E Ratio
Rapporto P/E
Forward P/E
46.97x
P/E Forward
P/S Ratio
5.51x
Prezzo/Vendite
EV/EBITDA
60.37x
Valore Impresa/EBITDA
Rendimento Dividendi
Rendimento annuale da dividendi
Cap. di Mercato
1,6 Mrd. €
Capitalizzazione di Mercato
Crescita Ricavi
17.7%
Crescita Ricavi Anno su Anno
Margine di Profitto
-13.13%
Margine Netto
ROE
-7.14%
Return on Equity
Beta
0.93
Sensibilità al mercato
Interesse Corto
13.19%
% del flottante in vendita allo scoperto
Volume Medio
3,223,007
Volume Medio Giornaliero

Analisi della Valutazione

Segnale
N/A
vs. P/E medio S&P 500 (24,7x)
Consenso degli Analisti
Acquisto Forte
1 analisti
Prezzo Obiettivo Medio
13,65 €
+3.23% potenziale
Range Obiettivo
13,65 € – 13,65 €

Informazioni sull'Azienda

Settore: Healthcare Industria: Drug Manufacturers - Specialty & Generic Paese: United States Dipendenti: 405 Borsa: NMS

Dynavax Technologies Stock at a Glance

Dynavax Technologies (DVAX) is currently trading at 13,22 € with a market capitalization of 1,6 Mrd. €. The 52-week range spans from 0,00 € to 13,42 €; the current price is 1.5% below the yearly high. Year-over-year revenue growth stands at +17.7%.

💰 Dividendo

Dynavax Technologies currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Raccomandazioni degli Analisti

1 analysts rate Dynavax Technologies (DVAX) on consensus: Acquisto Forte. The average price target is 13,65 €, implying +3.23% from the current price. Analyst price targets range from 13,65 € to 13,65 €.

Tesi di Investimento: Punti di Forza e Debolezze

Punti di Forza
  • High gross margin of 61.6% — indicates pricing power
  • Analyst consensus: Strong Buy
  • Positive free cash flow
Debolezze
  • Currently unprofitable
  • High short interest (13.19%)

Panoramica Tecnica

MM 50 Giorni
11,81 €
+11.91% vs. prezzo
MM 200 Giorni
9,59 €
+37.9% vs. prezzo
Sotto Massimo 52S
−1.5%
13,42 €

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profilo di Rischio

Rischio di Mercato (Beta)
0.93 · Market-like
Moves less than the overall market
Short Interest
13.19% · High
% del flottante in vendita allo scoperto
Debt-to-Equity
54.15 · Moderate
Debito totale / patrimonio

The data points to relatively defensive market behavior, elevated short interest (13.19%).

Dati di Trading

50-Day MA: 11,81 €
200-Day MA: 9,59 €
Volume:
Volume Medio: 3,223,007
Ratio Corto: 2.81
Rapporto P/B: 3.41x
Debito/Patrimonio: 54.15x
Flusso di Cassa Libero: 44 M €

Where can I buy Dynavax Technologies?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Scroll to Top